Abstract
The retinoic acid receptor α (RARα) protein plays a central role in myeloid differentiation, and chromosomal translocations disrupting the RARα gene are implicated in the development of acute myeloid leukaemia (AML). To identify haemopoietic malignant disorders which may also be linked to RARα abnormalities, Southern blot analysis was performed in DNA from 153 patients with haematological malignancies other than AML FAB type M3 using RARα CDNA probes. Alterations of RARα were detected in 1/42 myelodysplastic syndromes (MDS), 2/24 AML, 3/47 B-chronic lymphocytic leukaemias (B-CLL), 0/40 lymphomas and 0/60 normal individuals. These data strongly suggest that alterations of RARα might predispose for myeloid and lymphoid disorders.
| Original language | English |
|---|---|
| Pages (from-to) | 738-741 |
| Number of pages | 4 |
| Journal | British Journal of Haematology |
| Volume | 104 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1999 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute myeloid leukaemia
- B-chronic lymphocytic leukaemia
- Myelodysplastic syndromes
- Retinoic acid receptor alpha
Fingerprint
Dive into the research topics of 'Alterations of the retinoic acid receptor α (RARα) gene in myeloid and lymphoid malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver